RxDoctor Payments Data

Cara Wolters, MD

Family Medicine · Sidney, OHNPI 1396109963

Payments from drug & device makers

$898in general payments, 2019–2025

Across 47 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$243
  • Novo Nordisk$175
  • Exact Sciences$101
  • Lilly USA, LLC$93
  • AstraZeneca$93
  • Amgen$52
  • plus $140 from 7 others

What the payments were for

  • Food & beverage$898100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$898 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$104,918
Medicare patients
250
Services billed
3,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide26$56,475
OzempicSemaglutide32$44,958
FarxigaDapagliflozin Propanediol34$44,726
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$24,369
JardianceEmpagliflozin26$19,301
MounjaroTirzepatide18$19,064
KerendiaFinerenone19$18,722
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$15,921
Spiriva RespimatTiotropium Bromide14$15,025
TradjentaLinagliptin12$10,324
MyrbetriqMirabegron13$7,519
Bevespi AerosphereGlycopyrrolate/Formoterol Fum13$5,974
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$4,920
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$4,465
Tizanidine Hcl35$2,681

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$93$75,53844 claims
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$93$66,62164 claims
Novo NordiskOzempic$175$44,95832 claims
BayerKerendia$30$18,72219 claims
Astellas Pharma US IncMyrbetriq$14$7,51913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sidney

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →